These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 2845061)
1. Effects of amiloride and 5-(N,N-hexamethylene)amiloride on dopaminergic and cholinergic neurotransmission. Zubieta JK; Cragoe EJ; Cubeddu LX J Pharmacol Exp Ther; 1988 Oct; 247(1):88-95. PubMed ID: 2845061 [TBL] [Abstract][Full Text] [Related]
2. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores. Parker EM; Cubeddu LX J Pharmacol Exp Ther; 1986 Apr; 237(1):179-92. PubMed ID: 3007736 [TBL] [Abstract][Full Text] [Related]
3. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. II. Release in the presence of vesicular transmitter stores. Parker EM; Cubeddu LX J Pharmacol Exp Ther; 1986 Apr; 237(1):193-203. PubMed ID: 3007738 [TBL] [Abstract][Full Text] [Related]
4. Na(+)-Ca2+ exchange activity in central nerve endings. II. Relationship between pharmacological blockade by amiloride analogues and dopamine release from tuberoinfundibular hypothalamic neurons. Taglialatela M; Canzoniero LM; Cragoe EJ; Di Renzo G; Annunziato L Mol Pharmacol; 1990 Sep; 38(3):393-400. PubMed ID: 2402228 [TBL] [Abstract][Full Text] [Related]
5. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine. Baud P; Arbilla S; Cantrill RC; Scatton B; Langer SZ J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699 [TBL] [Abstract][Full Text] [Related]
6. Transmitter release by non-receptor activation of the alpha-subunit of guanine nucleotide regulatory protein in rat striatal slices. Zelles T; Chernaeva L; Baranyi M; Déri Z; Adam-Vizi V; Vizi ES J Neurosci Res; 1995 Oct; 42(2):242-51. PubMed ID: 8568925 [TBL] [Abstract][Full Text] [Related]
7. Interactions between endogenous dopamine and dopamine agonists at release modulatory receptors: multiple effects of neuronal uptake inhibitors on transmitter release. Hoffmann IS; Talmaciu RK; Cubeddu LX J Pharmacol Exp Ther; 1986 Aug; 238(2):437-46. PubMed ID: 2942676 [TBL] [Abstract][Full Text] [Related]
8. Amphetamine inhibits the electrically evoked release of [3H]dopamine from slices of the rabbit caudate. Kamal LA; Arbilla S; Galzin AM; Langer SZ J Pharmacol Exp Ther; 1983 Nov; 227(2):446-58. PubMed ID: 6631724 [TBL] [Abstract][Full Text] [Related]
9. Ionic mechanism of dopaminergic and muscarinic auto- and heteroreceptor activation in superfused striatal slices: role of extracellular chloride. Diliberto PA; Garrett LJ; James MK; Cubeddu LX J Pharmacol Exp Ther; 1987 Mar; 240(3):795-801. PubMed ID: 3559975 [TBL] [Abstract][Full Text] [Related]
10. Comparative dopamine-cholinergic mechanisms in the olfactory tubercle and the striatum: effects of metoclopramide. Suarez-Roca H; Lovenberg T; Cubeddu LX J Pharmacol Exp Ther; 1987 Dec; 243(3):840-51. PubMed ID: 3320346 [TBL] [Abstract][Full Text] [Related]
11. Effects of low extracellular chloride on dopamine release and the dopamine transporter. Diliberto PA; Jeffs RA; Cubeddu LX J Pharmacol Exp Ther; 1989 Feb; 248(2):644-53. PubMed ID: 2521901 [TBL] [Abstract][Full Text] [Related]
13. Effects of the antiparkinsonian drug budipine on neurotransmitter release in central nervous system tissue in vitro. Jackisch R; Huang HY; Reimann W; Limberger N J Pharmacol Exp Ther; 1993 Feb; 264(2):889-98. PubMed ID: 8094757 [TBL] [Abstract][Full Text] [Related]
14. Impact of L-dopa on striatal acetylcholine release: effects of 6-hydroxydopamine. Jackson D; Abercrombie ED; Zigmond MJ J Pharmacol Exp Ther; 1993 Nov; 267(2):912-8. PubMed ID: 8246167 [TBL] [Abstract][Full Text] [Related]
15. Effects of adenosine A1 and A2 receptor activation on electrically evoked dopamine and acetylcholine release from rat striatal slices. Jin S; Johansson B; Fredholm BB J Pharmacol Exp Ther; 1993 Nov; 267(2):801-8. PubMed ID: 7902434 [TBL] [Abstract][Full Text] [Related]
16. Evidence for autoreceptor modulation of endogenous dopamine release from rabbit caudate nucleus in vitro. Parker EM; Cubeddu LX J Pharmacol Exp Ther; 1985 Feb; 232(2):492-500. PubMed ID: 3155797 [TBL] [Abstract][Full Text] [Related]
17. Changes in sensitivity of release modulating dopamine autoreceptors after chronic treatment with haloperidol. Nowak JZ; Arbilla S; Galzin AM; Langer SZ J Pharmacol Exp Ther; 1983 Aug; 226(2):558-64. PubMed ID: 6875865 [TBL] [Abstract][Full Text] [Related]
18. Robust modulation of [3H]dopamine release from rat striatal slices by D-2 dopamine receptors. Dwoskin LP; Zahniser NR J Pharmacol Exp Ther; 1986 Nov; 239(2):442-53. PubMed ID: 3772803 [TBL] [Abstract][Full Text] [Related]
19. Membrane events and ionic processes involved in dopamine release from tuberoinfundibular neurons. II. Effect of the inhibition of the Na+-Ca++ exchange by amiloride. Taglialatela M; Amoroso S; Canzoniero LM; Di Renzo GF; Annunziato L J Pharmacol Exp Ther; 1988 Aug; 246(2):689-94. PubMed ID: 2841453 [TBL] [Abstract][Full Text] [Related]
20. Evidence for multiple dopamine receptors involved in the modulation of acetylcholine release in the striatum. Hársing LG; Vizi ES Pol J Pharmacol Pharm; 1985; 37(3):383-96. PubMed ID: 2866504 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]